Pre-operative chemoradiation therapy with 5-fluorouracil and low-dose daily cisplatin for esophageal cancer: A preliminary report

Japanese Journal of Clinical Oncology

Volumn 29, Issue 3, 1999, Pages 132-136

  Shimoyama, Shouji ^a,b   Konishi, Toshiro ^a   Kawahara, Masaki ^a,b   Kaminishi, Michio ^b   Ito, Akihiko ^a   Hojo, Keiichi ^a   Takeda, Yuichi ^a   Oba, Hiroshi ^a   Shimizu, Seiichiro ^a  

^a Showa General Hospital   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Biochemical modulation; Chemoradiation therapy; Esophageal cancer; Radiosensitizing effect

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; RADIOSENSITIZING AGENT;

AGED; ARTICLE; CLINICAL TRIAL; DRUG ADMINISTRATION; ESOPHAGUS TUMOR; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; RADIATION-SENSITIZING AGENTS; TREATMENT OUTCOME;

EID: 0033091385     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.3.132     Document Type: Article

References (30)

1. Fink U, Stein HJ, Wilke H, Roder JD, Siewert JR. Multimodal treatment for squamous cell esophageal cancer. World J Surg 1995;19:198-204.
2. Fok M, Sham JST, Choy D, Cheng SWK, Wong J. Postoperative radiotherapy for carcinoma of the esophasus: A prospective, randomized controlled study. Surgery 1993;113:138-47.
3. Japanese Esophageal Oncology Group. A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Chest 1993;104:203-7.
4. Gianoux M, Roussel A, Paillot B, Gillet M, Schlag P, Favre J-P, et al. The value of preoperative radiotherapy in esophageal cancer. Results of a study of the E.O.R.T.C. World J Surg 1987;11:426-32.
5. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindestine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1988;96:242-8.
6. Schlag PM. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. Arch Surg 1992;127:1446-50.
7. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779-84.
8. Malhaire J-P, Labat J-P, Lozac'h P, Simon H, Lucas B, Topart P, et al. Preoperative concomitant radiochemotherapy in squamous cell carcinoma of the esophagus: Results of a study of 56 patients. Int J Radiat Oncol Biol Phys 1996;34:429-37.
9. Apinop C, Puttisak P, Preecha N. A prospective study of combined therapy in esophageal Cancer. Hepatogastroenterology 1994;41:391-3.
10. Naunheim KS, Petruska PJ, Roy TS, Andrus CH, Johnson FE, Schlueter J, et al. Preoperative chemotherapy and radiotherapy for esophageal carcinoma. J Thorac Cardiovasc Surg 1992;103:887-95.
11. Coia LR, Engstrom PF, Paul A. Nonsurgical management of esophageal cancer: Report of a study of combined radiotherapy and chemotherapy. J Clin Oncol 1987;5:1783-90.
12. John MJ, Flam MS, Mowry PA, Podolsky WJ, Xavier AM, Wittlinger PS. Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation. Cancer 1989;63:2397-403.
13. Richmond J, Seydel HG, Bae Y, Lewis J, Burdakin J, Jacobsen G. Comparison of three treatment strategies for esophageal cancer within a single institution. Int J Radiat Oncol Biol Phys 1987;13:1617-20.
14. Shirasaka T, Shimamoto Y, Ohshimo H, Saito H, Fukushima M. Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo. Cancer Chemother Pharmacol 1993;32:167-72.
15. Skov K, MacPhail S. Interaction of platinum drugs with clinically relevant X-ray doses in mammalian cells: A comparison of cisplatin, carboplatin, iproplatin, and tetraplatin. Int J Radiat Oncol Biol Phys 1991;20:22 -5.
16. Sun J-R, Brown JM. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin. Radiat Res 1993;133:252-6.
17. Schaake-Koning C, Van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, Houtte P, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992;326:524-30.
18. Shimoyama S, Konishi T, Kawahara M, Hojo K, Takeda Y, Nagayama T. Complete response of esophageal cancer achieved by combination therapy with 5-fluorouracil, low dose cisplatin, and radiation: Report of a case. Surg Today, 1998;28:1163-7.
19. Beahrs OH, Henson DE, Hutter RVP, Myers MH. Manual for Staging of Cancer, 3rd edn. Philadelphia: JB Lippincott 1988;63-5.
20. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
21. Lokich JJ, Ahlgren JD, Gullo JJ, Philips JA, Fryer JG. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: A Mid-Atlantic Oncology Program Study. J Clin Oncol 1989;7:425-32.
22. Nakajima Y, Miyamoto T, Tanabe M, Watanabe I, Terashima T. Enhancement of mammalian cell killing by 5-fluorouracil in combination with X-rays. Cancer Res 1979;39:3763-7.
23. Smalley SR, Kimler BF, Evans RG. 5-fluorouracil modulation of radiosensitivity in cultures human carcinoma cells. Int J Radiat Oncol Biol Phys 1991;20:207-11.
24. Shimoyama S, Kojima J, Kaminishi M. A case of complete response to esophageal cancer by a novel concurrent chemoradiation therapy. Hepatogastroenterology, (in press).
25. Herskovic A, Martz K, AI-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-8.
26. Araújo CMM, Souhami L, Gil RA, Carvalho R, Garcia JA, Froimtchuk MJ, et al. A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer 1991;67:2258-61.
27. MacFarlane SD, Hill LD, Jolly PC, Kozarek RA, Anderson RP. Improved results of surgical treatment for esophageal and gastroesophageal junction carcinomas after preoperative combined chemotherapy and radiation. J Thorac Cardiovasc Surg 1988;95:415-22.
28. Forastiere AA, Orringer MB, Perez-Tamayo C, Urba SG, Zahurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: Final report. J Clin Oncol 1993;11:1118-23.
29. Scheithauer W, Depisch D, Kornek G, Pidlich J, Rosen H, Karall M, et al. Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer. Cancer 1994;73:1562-8.
30. Vokes EE, Ratain MJ, Mick R, McEvilly JM, Haraf D, Kozloff M, et al. Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: A clinical and pharmacologic analysis. J Clin Oncol 1993;11:360-8.